Protein interacting with cyclin A1 (PICA1), encoded by the gene PICA1 in humans, is a protein known to engage in interactions with cyclin A1. Cyclin A1 is a member of the cyclin family, which plays a pivotal role in regulating the cell cycle. Cyclins, by forming complexes with cyclin-dependent kinases (CDKs), drive the progression of cells through the various phases of the cell cycle, including DNA replication and mitosis.PICA1 is specifically implicated in the regulation of the cell cycle during the transition between the G1 phase and the S phase, as well as the progression through the G2 and M phases. The interaction between PICA1 and cyclin A1 suggests a role for PICA1 in the control of cellular proliferation, possibly by influencing the activity of the cyclin A1-CDK complexes.
While the precise biological functions and mechanisms of action of PICA1 remain to be fully elucidated, it is hypothesized that PICA1 modulates the activity of cyclin A1, thus affecting the cell cycle and cellular division. This interaction suggests PICA1's potential involvement in the regulation of cell growth and maintenance of genomic stability, which are crucial for normal development and the prevention of oncogenesis.Mutations or aberrant expression of PICA1, or its binding partner cyclin A1, could lead to disruptions in cell cycle control and contribute to the pathogenesis of certain cancers where cell cycle dysregulation is a hallmark. Research into PICA1 and its interactions with cyclin A1 is important for understanding the complex regulatory networks governing the cell cycle and may reveal new targets for cancer therapy.In summary, PICA1 plays a significant role in cell cycle regulation by interacting with cyclin A1, influencing cellular proliferation and genomic stability, which are essential processes for normal cellular function and prevention of disease.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Palbociclib | 571190-30-2 | sc-507366 | 50 mg | $315.00 | ||
Palbociclib is a CDK4/6 inhibitor, potentially affecting cell cycle regulation and indirectly impacting PCCA1. | ||||||
Flavopiridol Hydrochloride | 131740-09-5 | sc-207687 | 10 mg | $311.00 | ||
Flavopiridol inhibits various cyclin-dependent kinases (CDKs), possibly influencing PCCA1-related pathways. | ||||||
Roscovitine | 186692-46-6 | sc-24002 sc-24002A | 1 mg 5 mg | $92.00 $260.00 | 42 | |
Roscovitine selectively inhibits CDKs, potentially impacting cell cycle processes involving PCCA1. | ||||||
Olomoucine | 101622-51-9 | sc-3509 sc-3509A | 5 mg 25 mg | $72.00 $274.00 | 12 | |
Olomoucine is a CDK inhibitor, which could indirectly affect PCCA1's function in cell cycle regulation. | ||||||
Dinaciclib | 779353-01-4 | sc-364483 sc-364483A | 5 mg 25 mg | $242.00 $871.00 | 1 | |
Dinaciclib is a potent CDK inhibitor, potentially influencing cyclin A1-related pathways and thereby PCCA1. | ||||||
Purvalanol B | 212844-54-7 | sc-361300 sc-361300A | 10 mg 50 mg | $199.00 $846.00 | ||
Purvalanol A is a selective inhibitor of CDKs, potentially impacting PCCA1's interaction with cyclin A1. | ||||||
AZD 5438 | 602306-29-6 | sc-361115 sc-361115A | 10 mg 50 mg | $205.00 $865.00 | ||
AZD5438 inhibits CDK1, CDK2, and CDK9, which could affect cyclin A1-related processes and PCCA1. | ||||||
Ribociclib | 1211441-98-3 | sc-507367 | 10 mg | $450.00 | ||
Ribociclib selectively inhibits CDK4/6, potentially impacting cell cycle regulation and PCCA1. | ||||||
SNS-032 | 345627-80-7 | sc-364621 sc-364621A | 5 mg 10 mg | $169.00 $262.00 | ||
SNS-032 is a potent inhibitor of CDK2, CDK7, and CDK9, potentially influencing PCCA1-related pathways. | ||||||
Abemaciclib | 1231929-97-7 | sc-507342 | 10 mg | $110.00 | ||
Abemaciclib is another CDK4/6 inhibitor, which might indirectly affect PCCA1's function in the cell cycle. | ||||||